Information for Health Professionals

Clinically Tested

MigraPure has been tested in a double-blind, placebo-controlled clinical trial conducted by three top headache experts with results published in top-tier medical journals.

MigraPure showed:

High efficacy rates for migraine relief and associated symptoms

An excellent safety profile

MigraPure provides a side-effect profile similar to placebo

MigraPure was well tolerated and no serious adverse events were reported

MigraPure was Clinically Tested The results authored by Dr. Roger Cady and Dr. Jerome Goldstein and Dr. Robert Nett, et al, with results published in: A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesic M*) in the Treatment of Migraines in Headache: The Journal of Head and Face Pain, 2011: 51:1078-1086



Sublingual administration allows the immediate absorption of full-strength active ingredients through the capillaries under the tongue. Users report that relief often starts in minutes.

Sublingual delivery is efficient and superior because: 

It is up to 60% faster than pills

Avoids the “first pass” breakdown of active ingredients digested by the stomach and liver








You should not take MigraPure® if:

You are pregnant or breast feeding

If you have a known allergy to any of the ingredients

Scientific and Clinical History of Sublingual Feverfew and Ginger as a Treatment for Migraine Headache

The following is a listing of clinical studies and subsequent articles resulting from the sublingual homeopathic formulations of Feverfew 3X/Ginger 2X created by DMR Biologics LLC Founder Russ Mitchell. The original formulation utilized a water base and was later upgraded to a lipid base. These studies were all designed using the formulations as an acute treatment for migrainous headaches and associated symptoms.

The patented lipid-based LipiGesic formulation has been licensed to DMR Biologics LLC and has been renamed MigraPure. All future products based on the patented formulation will be marketed under the MigraPure banner.